Preferences
Related Series
Multichannel 1.5T MR
Healthcare providers and Medical Equipment vendors requested that KLAS complete this multichannel MR 1.5T research. The MR modality is increasingly used to perform such scans as Cardiac MR, Breast MR, and fMRI.
While MR functionality continues to rapidly advance, this research helps providers separate myth from fact and marketing hype from reality in order to anticipate the actual clinical effectiveness of the modality, expected performance of the Medical Equipment product and related service, and the level of performance providers reported for each specific vendor.
Select Study Findings
- Overall scores ranged from 75.6 to 92.0 out of a possible 100. GE, Siemens and Toshiba scored above the MR average Performance Score of 84.7 while Philips scored below it. In contrast, all the Medical Equipment in the KLAS database had an average Total Performance Score of 83.5.
- The Percent of Positive Comments ranged from 43 percent to 81 percent with the MR average of 66 percent. In contrast, 67 percent of all the Medical Equipment commentary in the KLAS database is positive.
- Of the 79 respondents providing data for this research, 68 indicated that they also had a PACS solution implemented. GE and Philips sites reported using the PACS solution of their MR vendor as the most frequent alternative while Siemens and Toshiba most used those of third parties.
Vendors and Products Included in Study
- GE Signa HDx 1.5T MRI
- Hitachi Echelon (overview/technical assessment only)
- Philips Achieva 1.5T
- Siemens MAGNETOM Avanto 1.5T MRI
- Toshiba Vantage
Learn from the advice of 79 experienced MR users in this 198-page report.
Project Manager
Robert Ellis
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2024 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.